BECN1 and Alzheimer disease: Genetic manipulations that decrease Beclin 1 levels in AD transgenic mice reduce neuronal autophagy, disrupt lysosomes, promote intracellular and extracellular Aβ accumulation, and enhance neurodegeneration.